TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
NRIX

Nurix Therapeutics Inc

Healthcare · Biotechnology

22.60$ -1.2% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow NRIX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – -113.3% – – – – –
– -21.2% -7.4% +179.0% +77.7% +26.3% +20.3% +14.8%
– +18.3% +743.3% +267.4% +78.0% +19.7% +0.8% +11.9%
– +464.8% +1,040.6% +285.5% +60.7% – – –
– – +86.3% -75.0% -308.7% – -191.5% –
– +3.5% +175.8% +24.3% +116.3% -31.4% +10.4% +51.0%
– -78.8% -3,093.7% -57.4% – +151.1% -477.3% –
– +700.0% -56.3% -85.7% – – – –
– -76.2% +268,966.7% -54.6% -23.8% -97.3% +14,996.9% -50.9%
– +4.3% +816.4% -145.8% – – – +147.5%
– – – – – – – –

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?